Am J Epidemiol 2002; 156:95-109.
Copyright © 2002 by the
Johns Hopkins Bloomberg School of Public Health
HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW |
Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
1 Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
2 IRCCS, University of Milan, Milan, Italy.
3 Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
4 International Agency for Research on Cancer, Lyon, France.
5 University of Torino, Turin, Italy.
6 University of Aarhus, Aarhus C., Denmark.
7 National Institute of Environmental Health Sciences, Research Triangle Park, NC.
8 University of Pittsburgh, Pittsburgh, PA
9 Department of Clinical Pharmacology, University of Goettingen, Goettingen, Germany.
10 University of Newcastle upon Tyne, Newcastle upon Tyne, England
11 University of Washington, Seattle, WA.
12 afárik University, Koice, Slovak Republic.
13 Seoul National University, Seoul, South Korea.
14 Miyazaki Medical College, Miyazaki, Japan.
15 Universitat de Barcelona, Barcelona, Spain.
16 Harbor-UCLA Medical Center, Torrance, CA.
Smoking is a known risk factor for bladder cancer. The product of the GSTM1 gene, glutathione S-transferase M1 (GSTM1), is involved in the detoxification of polycyclic aromatic hydrocarbons found in tobacco smoke; a homozygous deletion of this gene in approximately 50% of Caucasians and Asians results in a lack of GSTM1 enzyme activity. Most studies examining the relation between bladder cancer and GSTM1 have reported an increased risk associated with a lack of GSTM1 activity. The authors performed meta- and pooled analyses of published and unpublished, case-control, genotype-based studies that examined this association (17 studies, 2,149 cases, 3,646 controls) and excluded studies conducted in populations with a high prevalence of exposure to known bladder cancer risk factors other than tobacco smoke. Using random effects models in the meta-analysis, the authors obtained a summary odds ratio of 1.44 (95% confidence interval (CI): 1.23, 1.68) for GSTM1 null status with all studies included. Results from studies with at least 100 cases and 100 controls produced a summary odds ratio of 1.42 (95% CI: 1.26, 1.60). Pooled analyses using original data sets from 10 studies (1,496 cases and 1,444 controls) and adjusting for age, sex, and race produced similar results. There was no evidence of multiplicative interaction between the GSTM1 null genotype and ever smoking in relation to bladder cancer, although there was a suggestion of additive interaction (additive interaction = 0.45, 95% CI: –0.03, 0.93). These results indicate that, among populations studied to date, GSTM1 null status is associated with a modest increase in the risk of bladder cancer. Am J Epidemiol 2002;156:95–109.
bladder neoplasms; epidemiology; genetics; glutathione transferase
Abbreviations: Abbreviations: CI, confidence interval; CYP, cytochrome P450; GST, glutathione S-transferase; GSTM1, glutathione S-transferase M1; OR, odds ratio.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Sasaki, M. Horikawa, K. Orikasa, M. Sato, Y. Arai, Y. Mitachi, M. Mizugaki, M. Ishikawa, and M. Hiratsuka Possible Relationship Between the Risk of Japanese Bladder Cancer Cases and the CYP4B1 Genotype Jpn. J. Clin. Oncol., September 1, 2008; 38(9): 634 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Taioli Gene-environment interaction in tobacco-related cancers Carcinogenesis, August 1, 2008; 29(8): 1467 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Yuan, K. K. Chan, G. A. Coetzee, J.E. Castelao, M. A. Watson, D. A. Bell, R. Wang, and M. C. Yu Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer Carcinogenesis, July 1, 2008; 29(7): 1386 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sanderson, G. Salanti, and J. Higgins Joint Effects of the N-Acetyltransferase 1 and 2 (NAT1 and NAT2) Genes and Smoking on Bladder Carcinogenesis: A Literature-based Systematic HuGE Review and Evidence Synthesis Am. J. Epidemiol., October 1, 2007; 166(7): 741 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Murta-Nascimento, D. T. Silverman, M. Kogevinas, M. Garcia-Closas, N. Rothman, A. Tardon, R. Garcia-Closas, C. Serra, A. Carrato, C. Villanueva, et al. Risk of Bladder Cancer Associated with Family History of Cancer: Do Low-Penetrance Polymorphisms Account for the Increase in Risk? Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1595 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Jiang, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, and M. C. Yu Environmental Tobacco Smoke and Bladder Cancer Risk in Never Smokers of Los Angeles County Cancer Res., August 1, 2007; 67(15): 7540 - 7545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kellen, M. Hemelt, K. Broberg, K. Golka, V. N. Kristensen, R. J. Hung, G. Matullo, R. D. Mittal, S. Porru, A. Povey, et al. Pooled Analysis and Meta-analysis of the Glutathione S-Transferase P1 Ile 105Val Polymorphism and Bladder Cancer: A HuGE-GSEC Review Am. J. Epidemiol., June 1, 2007; 165(11): 1221 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rothman, M. Garcia-Closas, and D. W Hein Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned Int. J. Epidemiol., February 1, 2007; 36(1): 23 - 28. [Full Text] [PDF]
|
|
|
|
|
|
E. S. Peters, M. D. McClean, C. J. Marsit, B. Luckett, and K. T. Kelsey Glutathione S-Transferase Polymorphisms and the Synergy of Alcohol and Tobacco in Oral, Pharyngeal, and Laryngeal Carcinoma. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2196 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P A Ioannidis Commentary: Grading the credibility of molecular evidence for complex diseases Int. J. Epidemiol., June 1, 2006; 35(3): 572 - 578. [Full Text] [PDF]
|
|
|
|
|
|
R. Lai, L. Crevier, and L. Thabane Genetic Polymorphisms of Glutathione S-Transferases and the Risk of Adult Brain Tumors: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1784 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Broberg, J. Bjork, K. Paulsson, M. Hoglund, and M. Albin Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer Carcinogenesis, July 1, 2005; 26(7): 1263 - 1271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ntais, A. Polycarpou, and J. P.A. Ioannidis Association of GSTM1, GSTT1, and GSTP1 Gene Polymorphisms with the Risk of Prostate Cancer: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 176 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Vogl, E. Taioli, C. Maugard, W. Zheng, L. F. Ribeiro Pinto, C. Ambrosone, F. F. Parl, V. Nedelcheva-Kristensen, T. R. Rebbeck, P. Brennan, et al. Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1473 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanyal, F. Festa, S. Sakano, Z. Zhang, G. Steineck, U. Norming, H. Wijkstrom, P. Larsson, R. Kumar, and K. Hemminki Polymorphisms in DNA repair and metabolic genes in bladder cancer Carcinogenesis, May 1, 2004; 25(5): 729 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wacholder, S. Chanock, M. Garcia-Closas, L. El ghormli, and N. Rothman Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies J Natl Cancer Inst, March 17, 2004; 96(6): 434 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D Tobin, C. Minelli, P. R Burton, and J. R Thompson Commentary: Development of Mendelian randomization: from hypothesis test to 'Mendelian deconfounding' Int. J. Epidemiol., February 1, 2004; 33(1): 26 - 29. [Full Text] [PDF]
|
|
|
|
|
|
H. Ahsan and A. G. Rundle Measures of genotype versus gene products: promise and pitfalls in cancer prevention Carcinogenesis, September 1, 2003; 24(9): 1429 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Cunningham, M. S. Bogdanffy, T. R. Zacharewski, and R. N. Hines Workshop Overview: Use of Genomic Data in Risk Assessment Toxicol. Sci., June 1, 2003; 73(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Little, M. J. Khoury, L. Bradley, M. Clyne, M. Gwinn, B. Lin, M.-L. Lindegren, and P. Yoon The Human Genome Project Is Complete. How Do We Develop a Handle for the Pump? Am. J. Epidemiol., April 15, 2003; 157(8): 667 - 673. [Full Text] [PDF]
|
|
|
|
|
|
RE: "POOLED ANALYSIS AND META-ANALYSIS OF GLUTATHIONE S-TRANSFERASE M1 AND BLADDER CANCER: A HuGE REVIEW" Am. J. Epidemiol., September 1, 2002; 156(5): 492 - 492. [Full Text] [PDF]
|
|